Antagonist: Difference between revisions

From The School of Biomedical Sciences Wiki
Jump to navigation Jump to search
Nnjm2 (talk | contribs)
No edit summary
mNo edit summary
Line 3: Line 3:
Pharmacological antagonists can be further characterised as:  
Pharmacological antagonists can be further characterised as:  


*[[Competitive antagonists|Competitive]] which binds to the binding site of a receptor and can be overcome by increasing the concentration of an [[agonist|agonist]] (competitor).  
*[[Competitive antagonists|Competitive]] which binds to the binding site of a receptor and can be overcome by increasing the concentration of an [[Agonist|agonist]] (competitor).  
*[[Irreversible competitive antagonist|Irreversible competitive]] which forms a [[Covalent_bond|covalent bond]] with the receptor.  
*[[Irreversible competitive antagonist|Irreversible competitive]] which forms a [[Covalent bond|covalent bond]] with the receptor.  
*[[Non-competitive antagonist|Non-competitive antagonists]] which blocks the [[signal transduction|signal transduction]] event of the [[receptor|receptor]].
*[[Non-competitive antagonist|Non-competitive antagonists]] which blocks the [[Signal transduction|signal transduction]] event of the [[Receptor|receptor]].


A pharmacalogical example of an antagonist is [[Tamoxifen|Tamoxifen]], a drug which acts on estrogen receptor. Also see [[Agonist|agonist]].
A pharmacalogical example of an antagonist is [[Tamoxifen|Tamoxifen]], a drug which acts on [[Oestrogen|estrogen]] receptor. See also [[Agonist|agonist]].

Revision as of 14:05, 19 October 2013

A compound (usually synthetic) that inhibits the action of its natural counterpart by binding to a receptor or protein. There are three classes of antagonist, chemical, physiological and pharmacological.

Pharmacological antagonists can be further characterised as:

A pharmacalogical example of an antagonist is Tamoxifen, a drug which acts on estrogen receptor. See also agonist.